CoChat

Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men?

Ahmed, Ashraf H., Gordon, Richard D., Taylor, Paul J., Ward, Gregory, Pimenta, Eduardo, Stowasser, Michael · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Because primary aldosteronism is not uncommon, specifically treatable and in some cases curable, and carries higher risks for cardiovascular morbidity and mortality than essential hypertension, screening hypertensive patients for its presence by measuring aldosterone to renin ratio (ARR) is increasingly common. A significantly higher false-positive ARR rate for women than men, resulting in unnecessary suppression tests has previously been reported. METHODS: Using a new, highly accurate aldosterone assay and both of the currently widely used renin assays, ARR was measured in 19 normal, ovulating women at three time points in the menstrual cycle and compared with single measurements in 21 normal males of similar age. RESULTS: ARRs in males were possibly too well down in the current normal range. Although normotensive and normokalemic, two women had raised ARRs in the luteal phase but only when direct renin concentration (DRC) was used. Their DRC levels were low at all sampling times [despite midrange plasma renin activity levels], whereas their progesterone and aldosterone levels were highest for the group. Saline suppression testing, performed in one of them, showed normal aldosterone suppressibility. CONCLUSION: False-positive ARRs in normal women during the luteal phase only when DRC is used may explain the higher incidence of false-positive ARRs in hypertensive women than men and suggest the following: 1) plasma renin activity is preferable to DRC in determination of ARR and 2) new reference ranges for ARR that take into account gender and sex hormone levels are required.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2010-1355

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 29 references

Cited by

See all 96

Metadata

Authors
Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M.
Affiliations
  • The University of Queensland (AU)
  • Sullivan Nicolaides Pathology (AU)
Corresponding author
Stowasser, Michael
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-02
Volume
96
Issue
2
Pages
E340-E346
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1988501908
Cited by
96
References
29
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 5 · 2017: 13 · 2016: 5 · 2015: 4 · 2014: 11 · 2013: 7 · 2012: 2
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
primary aldosteronism, aldosterone-renin ratio, false-positive screening results, sex differences, menstrual cycle, luteal phase, progesterone, plasma renin activity, reference values, hypertension screening
MeSH terms
Adult, Aldosterone, Mineralocorticoid Receptor Antagonists, Chromatography, High Pressure Liquid, False Positive Reactions, Female, Follicle Stimulating Hormone, Humans, Hydrocortisone, Hyperaldosteronism, Immunoassay, Male, Menstrual Cycle, Progesterone, Renin, Sex Characteristics, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men? https://app.cochat.ai/papers/10.1210/jc.2010-1355
The paper
Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2011). Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men? The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-1355

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.